Allarity Therapeutics has established a facility in Horsholm, Northern Europe, and the FDA requires CLIA certification for biomarker testing.
1 report, 1 independent
Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Allarity Therapeutics has established a facility in Horsholm, Northern Europe, and the FDA requires CLIA certification for biomarker testing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Northern Europe
northern region of the European continent
Related events
- Amy Brenner hopes that a favorable FDA ruling will allow for more peptide products, noting her offices are in Kenwood and Mason.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- AOTI Inc.'s therapy received regulatory clearance from the FDA, with the company based in Galway and Oceanside.
- FDA announced regulatory clearance in Salt Lake City on September 25, 2026.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.